Higher midlife vitamin D levels linked to lower brain tau protein

A new study has found that adults with higher vitamin D levels in their 30s and 40s tend to have lower levels of tau protein in their brains about 16 years later. Tau is a key biomarker associated with dementia. The research, published this week, highlights a potential modifiable risk factor for brain health.

Researchers followed 793 adults who were around 39 years old on average and free of dementia at the study's start. They measured participants' blood vitamin D levels initially and conducted brain scans roughly 16 years later to assess tau and amyloid beta proteins, both linked to Alzheimer's disease. Levels above 30 nanograms per milliliter were deemed high, while those below were low; 34% of participants had low levels, and just 5% reported taking vitamin D supplements. After adjusting for age, sex, and depression symptoms, higher vitamin D was associated with lower tau levels, but not with amyloid beta.

Verwandte Artikel

Illustration of a doctor reviewing Alzheimer’s blood test results influenced by kidney problems, for news article on study findings.
Bild generiert von KI

Kidney problems may skew Alzheimer’s blood test results, study suggests

Von KI berichtet Bild generiert von KI Fakten geprüft

A large study published in Neurology finds that impaired kidney function is linked to higher levels of Alzheimer’s biomarkers in the blood, without increasing overall dementia risk. However, among people who already have elevated biomarker levels, poor kidney health may hasten when dementia symptoms appear, underscoring the need to factor kidney function into interpretation of Alzheimer’s blood tests.

Scientists at Washington University School of Medicine in St. Louis have developed a blood test that estimates when Alzheimer's symptoms may begin, using levels of the protein p-tau217. The model predicts onset within about three to four years, potentially aiding clinical trials and early interventions. This advance relies on data from 603 older adults in ongoing studies.

Von KI berichtet

New research from the University of Southern California suggests that subtle declines in brain blood flow and oxygen delivery may be early indicators of Alzheimer's disease. The study, published in Alzheimer's and Dementia, used noninvasive scans to connect vascular health with amyloid plaques and hippocampal shrinkage. These findings highlight the role of brain circulation in the disease process beyond traditional markers like amyloid and tau.

A large-scale international study has found that age-related memory decline stems from broad structural changes across the brain, rather than a single region or gene. Analyzing over 10,000 MRI scans from thousands of healthy adults, researchers observed that brain shrinkage's impact on memory intensifies nonlinearly in later life. The findings highlight a distributed vulnerability that accelerates memory loss once a tipping point is reached.

Von KI berichtet

A 20-year randomized controlled trial has shown that cognitive speed training, combined with booster sessions, reduces the risk of dementia diagnosis by 25 percent among older adults. The study, involving over 2,800 participants aged 65 and older, focused on a computer-based task requiring quick recall of visual details. While results are promising, experts urge caution due to the study's multiple outcome measures.

Older adults with weaker or more irregular daily rest-activity rhythms were more likely to be diagnosed with dementia over about three years, according to a study published in *Neurology*. The research also linked later-afternoon activity peaks to higher dementia risk, though it did not establish that disrupted circadian rhythms cause dementia.

Von KI berichtet

Prof KVS Hari, director of the Centre for Brain Research at IISc Bengaluru, emphasized digital biomarkers for early detection and prevention of dementia. He noted that India's rapidly aging population makes dementia a major public health challenge. The centre focuses on data collection and AI to understand disease progression in the Indian context.

 

 

 

Diese Website verwendet Cookies

Wir verwenden Cookies für Analysen, um unsere Website zu verbessern. Lesen Sie unsere Datenschutzrichtlinie für weitere Informationen.
Ablehnen